Explore popular drugs in clinical trials

Check which drugs are currently being frequently studied.

See also our rare diseases glossary and popular diseases list.

Starting by letter

To open the drugs glossary, select a letter from the list below.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All drugs

Most popular drugs

The list below features the most popular substances currently involved in ongoing clinical trials.

Drug	trials
Pembrolizumab	438
Sodium Chloride	402
Carboplatin	327
Cisplatin	273
Paclitaxel	242
Fluorouracil	223
Oxaliplatin	215
Nivolumab	203
Dexamethasone	201
Rituximab	186
Cyclophosphamide	183
Durvalumab	156
Bevacizumab	156
Paracetamol	155
Capecitabine	151
Atezolizumab	145
Prednisone	125
Docetaxel	125
Tocilizumab	120
Prednisolone	116
Mycophenolate Mofetil	112
Etoposide	112
Gemcitabine	111
Venetoclax	111
Pemetrexed	108
Doxorubicin Hydrochloride	104
Lenalidomide	97
Infliximab	94
Ipilimumab	88
Folinic Acid	86
Acetylsalicylic Acid	85
Semaglutide	84
Placebo	82
Methotrexate	77
Cytarabine	77
Daratumumab	77
Fludarabine Phosphate	75
Letrozole	73
Calcium Folinate	72
Bortezomib	70
Olaparib	69
Gemcitabine Hydrochloride	68
Dapagliflozin	67
Obinutuzumab	66
Azacitidine	65
Trastuzumab	63
Cetuximab	61
Tacrolimus	61
Methylprednisolone	61
Fulvestrant	61
Lenvatinib	60
Irinotecan Hydrochloride Trihydrate	58
Vincristine Sulfate	57
Irinotecan	56
Temozolomide	54
Cemiplimab	54
Trastuzumab Deruxtecan	53
Enzalutamide	51
Dexamethasone Sodium Phosphate	50
Betamethasone Sodium Phosphate	48
Exemestane	48
Apixaban	48
Codeine Phosphate	48
Anastrozole	47
Hydrocortisone	46
Potassium Chloride	46
Empagliflozin	46
Lidocaine Hydrochloride	45
Ribociclib	45
Adalimumab	43
Abemaciclib	43
Doxorubicin	43
Amoxicillin	42
Clopidogrel	42
Pertuzumab	41
Ruxolitinib	41
Tenofovir Alafenamide	40
Rivaroxaban	40
Pomalidomide	40
Ropivacaine Hydrochloride	39
Ibrutinib	39
Oxygen	39
Propofol	39
Pemetrexed Disodium	39
Palbociclib	38
Metformin Hydrochloride	38
Ifosfamide	38
Carfilzomib	37
Dostarlimab	37
Cyclophosphamide Monohydrate	37
Bendamustine Hydrochloride	37
Clavulanic Acid	37
Sulfamethoxazole	36
Osimertinib	36
Trimethoprim	36
Isatuximab	36
Emtricitabine	36
Dexamethasone Phosphate	36
Acalabrutinib	36
Tremelimumab	35

New drugs in trials

The list below features the new substances involved to ongoing clinical trials.

#1 AZD0120

Clinical trials are investigating AZD0120 in people with relapsed or refractory multiple myeloma, a cancer that has returned or no longer responds to treatment.

21 hours ago

#2 STREPTOCOCCUS VIRIDANS

Clinical trials investigating "STREPTOCOCCUS VIRIDANS" are studying whether a related study treatment can reduce respiratory infections in children.

21 hours ago

#3 STREPTOCOCCUS PYOGENES

Clinical trials investigating STREPTOCOCCUS PYOGENES are studying a treatment called PMBL (Ismigen) in children with respiratory tract infections.

21 hours ago

#4 AZD1163

Clinical trials are investigating AZD1163 in adults with moderately to severely active rheumatoid arthritis.

21 hours ago

#5 AZD5335

Clinical trials are investigating AZD5335 in women with advanced platinum-resistant epithelial ovarian cancer.

21 hours ago

#6 IMB 101

Clinical trials are studying NAV-240 in adults with moderate-to-severe hidradenitis suppurativa.

21 hours ago

All drugs

11
Aztreonam

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Bacterial Infections and Mycoses, Diseases, Nervous System Diseases, Respiratory Tract Diseases, Skin and Connective Tissue Diseases

Aztreonam is an antibiotic medication that has been the subject of several clinical trials exploring its potential uses in treating various infections. This article summarizes key findings from recent clinical trials investigating aztreonam, particularly its inhaled formulation, for conditions like cystic fibrosis, bronchiectasis, and other bacterial infections. We’ll examine the drug’s efficacy, safety profile, and potential applications based on these clinical studies.

Related diseases and areas:
2
B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021)

Diseases, Nervous System Diseases, Virus Diseases

This article discusses a clinical trial investigating the long-term safety, tolerability, and effectiveness of ofatumumab in patients with relapsing multiple sclerosis (RMS). The study is an open-label, single-arm, multi-center extension trial that aims to evaluate the drug’s performance over an extended period. While the main focus is on ofatumumab, the trial also includes information about a flu vaccine containing the B/Austria/1359417/2021-Like Strain (B/Singapore/Wuh4618/2021).

Related diseases and areas:
- Multiple sclerosis relapse
17
B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type)

Bacterial Infections and Mycoses, Cardiovascular Diseases, Diseases, Hemic and Lymphatic Diseases, Hormonal diseases, Immune System Diseases, Neoplasms, Respiratory Tract Diseases, Virus Diseases

This article summarizes several clinical trials investigating the use of B/Phuket/3073/2013-Like Virus in influenza vaccines. These studies aim to evaluate the safety, efficacy, and immune response of various influenza vaccine formulations containing this virus strain in different patient populations. The trials explore both standard-dose and high-dose quadrivalent influenza vaccines in healthy adults, elderly individuals, and patients with specific medical conditions.

Related diseases and areas:
- Influenza
1
B/Phuket/3073/2013-Like Virus (B/Singapore/Inftt-16-0610/2016, Wild Type)

Diseases, Nervous System Diseases

This article discusses clinical trials investigating the use of ofatumumab, a medication for treating relapsing multiple sclerosis (RMS). The trials aim to evaluate the long-term safety, tolerability, and effectiveness of ofatumumab in patients with RMS. These studies are important for understanding how the drug performs over extended periods and its potential benefits for managing this chronic neurological condition.

Related diseases and areas:
- Multiple sclerosis relapse
1
Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live

Bacterial Infections and Mycoses, Diseases

This article discusses the clinical trials of VE303, a novel drug containing live bacterial strains, including Bacilli, Cluster XVII, Strain Relative Clostridium_Aq Innocuum. The trials aim to evaluate VE303’s effectiveness in preventing recurrent Clostridioides difficile infection (CDI), a serious bacterial infection affecting the digestive system. The study focuses on assessing the drug’s safety, efficacy, and impact on patients’ quality of life compared to a placebo.

Related diseases and areas:
- Clostridium difficile infec…
1
Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Ramosum, Live

Digestive System Diseases, Diseases

This article explores the ongoing clinical trials of VE202, a novel drug containing live bacterial strains, including Bacilli, Cluster XVIII, Strain Relative Thomasclavelia Ramosum. The study focuses on evaluating the efficacy and safety of VE202 in treating patients with mild to moderate ulcerative colitis, a chronic inflammatory bowel disease. The trials aim to assess the drug’s potential in improving endoscopic response and overall patient outcomes.

Related diseases and areas:
- Colitis ulcerative
1
Bacilli, Cluster Xviii, Strain Relative Thomasclavelia Sp000508865, Live

Digestive System Diseases, Diseases

A new drug called VE202 is currently being tested in clinical trials for patients with mild to moderate ulcerative colitis. This innovative treatment contains live bacteria strains and is being evaluated for its effectiveness and safety in improving the symptoms of this inflammatory bowel disease. The trial aims to assess how well VE202 performs compared to a placebo in reducing inflammation in the colon and improving overall patient outcomes.

Related diseases and areas:
- Colitis ulcerative
3
Bacillus Calmette-Guérin (Bcg), Tice

Diseases, Neoplasms

Related diseases and areas:
- Bladder transitional cell c…
- Bladder cancer
6
Baclofen

Behavior and Behavior Mechanisms, Behavioral Disciplines and Activities, Diseases, Musculoskeletal Diseases, Nervous System Diseases, Psychiatry and Psychology

Baclofen, a muscle relaxant and antispastic agent, has been the subject of numerous clinical trials investigating its potential benefits for various medical conditions. This article provides an overview of recent studies examining the use of baclofen in treating muscle cramps, spasticity, alcohol use disorder, and other conditions. We’ll explore the drug’s effectiveness, safety profile, and different administration methods being researched.

Related diseases and areas:
3
Balcinrenone

Cardiovascular Diseases, Diseases, Male Urogenital Diseases, Metabolism, Phenomena and Processes

Balcinrenone is an investigational drug being studied in clinical trials for its potential benefits in treating various kidney and heart conditions. This article summarizes key information from several ongoing clinical trials evaluating balcinrenone, both alone and in combination with other medications like dapagliflozin. The trials aim to assess the drug’s safety, efficacy, and mechanisms of action in patients with chronic kidney disease, heart failure, and related conditions.

Related diseases and areas:
- Chronic kidney disease
- Cardiac failure
3
Baloxavir Marboxil

Bacterial Infections and Mycoses, Diseases, Environment and Public Health, Health Care, Respiratory Tract Diseases, Virus Diseases

This article explores the use of Baloxavir Marboxil, also known as Xofluza, in clinical trials for the treatment of influenza. These studies aim to assess the drug’s effectiveness, safety profile, and potential benefits in various patient populations, including children, adults, and hospitalized individuals. The trials also investigate Baloxavir Marboxil’s role in reducing viral transmission and its comparison to other antiviral treatments.

Related diseases and areas:
8
Balstilimab

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Diseases, Immune system processes, Neoplasms, Pathological Conditions, Signs and Symptoms, Phenomena and Processes, Skin and Connective Tissue Diseases, Therapeutics

Clinical trials are investigating Balstilimab in several cancer settings, including colorectal cancer, skin cancer, gastric cancer, and melanoma-related studies. These trials look at safety, response to treatment, surgery timing, and survival in selected patient groups. Most studies are early- to mid-phase and focus on patients with advanced, metastatic, or resectable disease.

Related diseases and areas:
31
Baricitinib

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Bacterial Infections and Mycoses, Digestive System Diseases, Diseases, Eye Diseases, Immune System Diseases, Immune system processes, Musculoskeletal Diseases, Nutritional and Metabolic Diseases, Phenomena and Processes, Respiratory Tract Diseases, Skin and Connective Tissue Diseases, Therapeutics, Virus Diseases

Baricitinib, also known by its brand name Olumiant, is a Janus kinase (JAK) inhibitor that has been the subject of numerous clinical trials for various medical conditions. This article explores the use of Baricitinib in clinical trials for rheumatoid arthritis, cutaneous lichen planus, Alzheimer’s disease, amyotrophic lateral sclerosis, pyoderma gangrenosum, and other conditions. We’ll examine the drug’s efficacy, safety profile, and potential benefits for patients with these diverse health issues.

Related diseases and areas:
1
Barium Sulfate

Neoplasms

This article explores the use of Barium Sulfate in clinical trials, specifically focusing on its role in a study involving advanced head and neck cancer patients. The trial aims to assess patient-reported outcomes related to swallowing and quality of life after different approaches to feeding tube placement during chemoradiotherapy treatment.

Related diseases and areas:
- Oropharyngeal cancer
7
Barzolvolimab

Digestive System Diseases, Diseases, Skin and Connective Tissue Diseases

Barzolvolimab, a novel monoclonal antibody, is currently being studied in several clinical trials for its potential in treating various skin conditions. These trials focus on chronic spontaneous urticaria, chronic inducible urticaria, prurigo nodularis, and eosinophilic esophagitis. The studies aim to evaluate the efficacy and safety of barzolvolimab in patients who have not responded well to conventional treatments, offering hope for those with persistent symptoms.

Related diseases and areas:
4
Basiliximab

Immune system processes, Pathological Conditions, Signs and Symptoms, Phenomena and Processes

Basiliximab, also known by its brand name Simulect, is a monoclonal antibody used in various clinical trials to prevent organ rejection and treat autoimmune conditions. This article explores the use of Basiliximab in different medical scenarios, including kidney transplantation, liver transplantation, ulcerative colitis, and graft-versus-host disease prevention. We’ll examine its effectiveness, safety profile, and potential benefits in comparison to other treatments.

Related diseases and areas:
- Renal transplant
2
Basimglurant

Diseases, Nervous System Diseases

Basimglurant, also known as NOE-101, is an experimental drug being studied in clinical trials for various neurological conditions. This article explores the use of Basimglurant in treating trigeminal neuralgia, major depressive disorder, and tuberous sclerosis complex. We’ll discuss the drug’s mechanism of action, its potential benefits, and the ongoing research to determine its safety and effectiveness.

Related diseases and areas:
- Tuberous sclerosis complex
- Trigeminal neuralgia
7
Batoclimab

Diseases, Eye Diseases, Immune System Diseases, Nervous System Diseases

Batoclimab, also known as IMVT-1401, is a novel drug currently being studied in clinical trials for various autoimmune disorders. This fully human anti-neonatal fragment crystallizable receptor (FcRn) monoclonal antibody shows potential in treating conditions such as Graves’ Disease, Thyroid Eye Disease, Generalized Myasthenia Gravis, and Chronic Inflammatory Demyelinating Polyneuropathy. The ongoing trials aim to evaluate the efficacy and safety of Batoclimab in managing these challenging autoimmune conditions.

Related diseases and areas:
1
Batoprotafib

Diseases, Neoplasms

Batoprotafib, also known as TNO155, is an investigational drug currently being studied in clinical trials for the treatment of advanced solid tumors, particularly those with specific genetic mutations. This article explores the ongoing research into Batoprotafib’s potential as a targeted therapy for cancer patients, including its use alone and in combination with other treatments.

Related diseases and areas:
7
Baxdrostat

Cardiovascular Diseases, Diseases

Baxdrostat, also known as CIN-107, is a novel drug being studied in clinical trials for the treatment of hypertension (high blood pressure). This aldosterone synthase inhibitor is showing promise in helping patients with uncontrolled and resistant hypertension who have not responded adequately to other medications. The trials are evaluating Baxdrostat’s safety, efficacy, and how it interacts with other drugs in the body.

Related diseases and areas:
2
Bay 2927088

Diseases, Neoplasms

A groundbreaking clinical trial is underway to assess the effectiveness and safety of BAY 2927088, a novel oral medication for patients with advanced non-small cell lung cancer (NSCLC) harboring HER2 mutations. This Phase 3 study aims to compare BAY 2927088 with standard of care treatments as a first-line therapy, potentially offering new hope for patients with this specific type of lung cancer.

Related diseases and areas:
2
Bay 3018250

Cardiovascular Diseases, Diseases

This article explores the ongoing clinical trial of BAY 3018250, a promising new drug being studied for the treatment of proximal deep vein thrombosis (DVT). The trial aims to assess the effectiveness and safety of BAY 3018250 in patients with this condition, comparing it to standard treatments. We’ll discuss the study’s objectives, eligibility criteria, and potential implications for future DVT treatment.

Related diseases and areas:
1
Bay 3283142

Cardiovascular Diseases, Diseases

A new clinical trial is underway to assess the effectiveness and safety of BAY 3283142, a potential treatment for chronic kidney disease. This study aims to determine how well the drug reduces albumin levels in urine, a key indicator of kidney function. The trial will involve patients with chronic kidney disease and will compare different doses of BAY 3283142 to a placebo, in addition to standard care treatments.

Related diseases and areas:
- Diabetic retinopathy
- Chronic kidney disease
1
Bbp-398

Diseases, Neoplasms

BBP-398, formerly known as IACS-15509, is a potent, selective, orally active allosteric inhibitor of SHP2, a tyrosine phosphatase that plays a key role in the RTK-MAPK signal transduction pathway. This article explores the ongoing clinical trials investigating BBP-398 as a potential treatment for various advanced solid tumors, including non-small cell lung cancer (NSCLC) with specific genetic mutations. These trials aim to evaluate the safety, efficacy, and optimal dosing of BBP-398 alone and in combination with other targeted therapies.

Related diseases and areas:
- K-ras gene mutation
4
Bcg (Bacillus Calmette-Guérin) Bacteria

Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Neoplasms, Virus Diseases

Related diseases and areas:
2
Bcmacp03

Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases, Neoplasms

BCMACP03 is an innovative CAR T-cell therapy being investigated for the treatment of relapsed or refractory multiple myeloma. This article explores the ongoing clinical trials evaluating the safety, efficacy, and long-term effects of BCMACP03 in patients who have exhausted other treatment options. We’ll delve into the study designs, eligibility criteria, and potential benefits of this cutting-edge therapy for multiple myeloma patients.

Related diseases and areas:
2
Bdc-1001

Diseases, Neoplasms

BDC-1001 is an innovative drug currently being studied in clinical trials for patients with HER2-positive cancers, particularly metastatic breast cancer and other solid tumors. This immune-stimulating antibody conjugate (ISAC) is designed to target HER2-expressing tumors and activate the body’s immune system to fight cancer. The ongoing trials aim to evaluate its effectiveness both as a single agent and in combination with other cancer treatments.

Related diseases and areas:
- Breast cancer metastatic
- Malignant mast cell neoplasm
4
Beclometasone Dipropionate

Diseases, Respiratory Tract Diseases

This article examines the use of Beclomethasone Dipropionate (BDP) in clinical trials for treating asthma and other respiratory conditions. BDP is an inhaled corticosteroid medication that helps reduce inflammation in the airways. We’ll look at studies testing different formulations, dosages, and applications of BDP to better understand its efficacy and safety profile in both adults and children with respiratory issues.

Related diseases and areas:
7
Beclometasone Dipropionate Anhydrous

Diseases, Immune System Diseases, Respiratory Tract Diseases

This article discusses clinical trials investigating the use of Beclometasone Dipropionate Anhydrous, a corticosteroid medication, in combination with other drugs for treating respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD). The trials aim to evaluate the efficacy, safety, and tolerability of different inhaler formulations containing this drug compared to existing treatments.

Related diseases and areas:
- Asthma
- Chronic obstructive pulmona…
2
Bedaquiline

Bacterial Infections and Mycoses, Diseases, Respiratory Tract Diseases

Bedaquiline is a novel antibiotic being studied in clinical trials for the treatment of multidrug-resistant tuberculosis (MDR-TB). This article summarizes key findings from several clinical trials evaluating the safety, efficacy, and pharmacokinetics of bedaquiline in adults and children with MDR-TB.

Related diseases and areas:
- Pulmonary tuberculosis
- Mycobacterium abscessus inf…
18
Belantamab Mafodotin

Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, Neoplasms

Belantamab mafodotin, also known as Blenrep, is an innovative drug being studied in clinical trials for the treatment of multiple myeloma and other blood cancers. This article examines ongoing research investigating its safety, efficacy, and optimal dosing regimens in various patient populations. We’ll explore how this targeted therapy is being evaluated as a monotherapy and in combination with other treatments across different stages of disease.

Related diseases and areas:
6
Belatacept

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Biological Phenomena, Circulatory and Respiratory Physiological Phenomena, Digestive System Diseases, Diseases, Immune System Diseases, Immune system processes, Investigative Techniques, Pathological Conditions, Signs and Symptoms, Phenomena and Processes, Surgical Procedures, Operative, Therapeutics, Virus Diseases

Belatacept is an innovative immunosuppressive drug being studied in clinical trials for kidney transplant recipients. It offers a potential alternative to traditional calcineurin inhibitors, with the aim of improving long-term kidney function and reducing side effects. This article summarizes key findings from recent clinical trials exploring the use of Belatacept in various kidney transplant scenarios.

Related diseases and areas:
- Renal transplant
- Complications of transplant…
13
Belimumab

Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, Immune System Phenomena, Immune system processes, Phenomena and Processes, Respiratory Tract Diseases, Skin and Connective Tissue Diseases

Belimumab, marketed under the brand name Benlysta, is a monoclonal antibody medication that has shown promise in treating various autoimmune conditions. This article explores the use of belimumab in clinical trials for conditions such as systemic lupus erythematosus (SLE), Sjögren’s syndrome, neuromyelitis optica spectrum disorders (NMOSD), and in transplant medicine. We’ll examine its mechanism of action, potential benefits, and safety profile across different studies.

Related diseases and areas:
1
Belinostat

Diseases, Neoplasms

Belinostat is an investigational drug being studied in clinical trials for various types of cancer, including lymphomas, solid tumors, and blood disorders. As a histone deacetylase (HDAC) inhibitor, belinostat works by blocking enzymes involved in cancer cell growth and survival. This article summarizes key findings from clinical trials evaluating belinostat’s safety, efficacy, and optimal dosing in different patient populations.

Related diseases and areas:
- Peripheral T-cell lymphoma …
5
Belumosudil Mesilate

Diseases, Immune System Diseases, Neoplasms

Belumosudil Mesilate, also known as KD025 or SAR445761, is a promising drug currently being studied in clinical trials for various conditions, including multiple myeloma and immune system disorders. These trials aim to evaluate the safety, effectiveness, and optimal dosing of the drug in both patients and healthy volunteers. The research spans different phases and explores the drug’s potential as a standalone treatment and in combination with other medications.

Related diseases and areas:
1
Belzupacap Sarotalocan

Diseases, Neoplasms

A groundbreaking Phase 3 clinical trial is underway to assess the effectiveness and safety of Belzupacap Sarotalocan (AU-011) in treating primary indeterminate lesions or small choroidal melanoma. This innovative drug, administered through a unique suprachoroidal injection method, offers hope for patients with these rare eye conditions. The study aims to compare the drug’s performance against a sham control, potentially paving the way for a new treatment option in ocular oncology.

Related diseases and areas:
16
Belzutifan

Diseases, Neoplasms

Belzutifan, also known as MK-6482 or WELIREG, is an innovative drug being studied in clinical trials for the treatment of various types of cancer. This article explores the use of Belzutifan in clinical trials, its potential benefits, and its impact on patients with advanced solid tumors, particularly renal cell carcinoma and Von Hippel-Lindau disease-associated cancers.

Related diseases and areas:
5
Bemarituzumab

Digestive System Diseases, Diseases, Neoplasms

Bemarituzumab is an investigational drug being studied in clinical trials for the treatment of various types of cancer, particularly advanced gastric and gastroesophageal junction cancers. This article explores the ongoing research on bemarituzumab, its potential benefits, and its role in combination with other cancer therapies.

Related diseases and areas:
2
Bemcentinib

Diseases, Neoplasms, Virus Diseases

Bemcentinib is an investigational drug being studied in clinical trials for various types of cancer and COVID-19. This article summarizes key information about ongoing clinical trials evaluating bemcentinib’s safety and effectiveness, either alone or in combination with other treatments, for conditions like lung cancer, leukemia, and COVID-19.

Related diseases and areas:
- Lung disorder
- Non-small cell lung cancer
2
Bemnifosbuvir Hemisulfate

Diseases, Virus Diseases

Bemnifosbuvir Hemisulfate is an investigational antiviral drug currently being studied in clinical trials for the treatment of COVID-19 and chronic hepatitis C virus (HCV) infection. These trials aim to evaluate the safety and efficacy of the drug in different patient populations, potentially offering new treatment options for these viral diseases.

Related diseases and areas:
- Chronic hepatitis C
- COVID-19
6
Bempedoic Acid

Cardiovascular Diseases, Diseases

Bempedoic acid is an innovative drug being studied in clinical trials for its potential to lower cholesterol levels and reduce cardiovascular risk. This article explores the use of bempedoic acid in various clinical trials, examining its efficacy, safety, and potential benefits for patients with hyperlipidemia and other cardiovascular risk factors.

Related diseases and areas:
1
Bempikibart

Diseases, Skin and Connective Tissue Diseases

A clinical trial is underway to assess the safety and efficacy of Bempikibart, also known as ADX-914, for patients with moderate to severe atopic dermatitis. This Phase 2a study aims to determine the optimal dosage and evaluate the drug’s effectiveness compared to a placebo. The trial involves adult patients who have not responded adequately to previous treatments and will help researchers understand the potential of Bempikibart in managing this chronic skin condition.

Related diseases and areas:
- Dermatitis atopic
5
Bendamustine

Hemic and Lymphatic Diseases, Neoplasms

Bendamustine is a chemotherapy drug that has shown promising results in clinical trials for treating various types of cancer. This article explores the use of bendamustine in clinical trials, focusing on its potential benefits, side effects, and effectiveness in treating different cancers such as lymphomas, leukemias, and solid tumors.

Related diseases and areas:
38
Bendamustine Hydrochloride

Diseases, Environment and Public Health, Hemic and Lymphatic Diseases, Immune System Diseases, Neoplasms, Therapeutics

Bendamustine Hydrochloride is an anticancer drug being studied in clinical trials for treating various types of cancer, including lymphomas, leukemias, and ovarian cancer. This article summarizes key information from several clinical trials investigating the efficacy and safety of Bendamustine Hydrochloride in different patient populations and cancer types.

Related diseases and areas:
2
Benfotiamine

Diseases, Immune System Diseases, Musculoskeletal Diseases, Nervous System Diseases, Nutritional and Metabolic Diseases

Benfotiamine, a synthetic derivative of thiamine (vitamin B1), has been the subject of numerous clinical trials investigating its potential therapeutic effects in various medical conditions. This article summarizes the findings from several studies exploring benfotiamine’s efficacy in treating Alzheimer’s disease, diabetic complications, vascular dysfunction, and other health issues. By examining these trials, we aim to provide an overview of benfotiamine’s potential benefits and its role in addressing different medical challenges.

Related diseases and areas:
- Rheumatoid arthritis
9
Benralizumab

Diseases, Hemic and Lymphatic Diseases, Respiratory Tract Diseases

Benralizumab is an innovative medication being studied in clinical trials for various eosinophilic conditions, including severe asthma, eosinophilic granulomatosis with polyangiitis (EGPA), and chronic rhinosinusitis. This article explores the use of benralizumab in clinical trials, its potential benefits, and its impact on patients with eosinophil-related disorders.

Related diseases and areas:
3
Benserazide Hydrochloride

Nervous System Diseases

This article discusses the use of Benserazide Hydrochloride, a component of Madopark tablets, in clinical trials for Parkinson’s disease treatment. While the main focus of the trial is on Montelukast, Madopark (containing Benserazide Hydrochloride and Levodopa) is used as a background therapy. The study aims to examine the effects of Montelukast on disease progression and symptoms in patients with mild to moderate Parkinson’s disease.

Related diseases and areas:
- Parkinson’s disease
3
Benzalkonium Chloride

Bacterial Infections and Mycoses, Diseases, Eye Diseases, Musculoskeletal Diseases

Benzalkonium chloride (BAC) is a versatile compound being studied in various clinical trials for its potential medical applications. This article explores the ongoing research into BAC’s use in different areas, including eye care, oral health, contraception, and disinfection. We’ll examine how researchers are investigating its effectiveness and safety across multiple medical conditions and applications.

Related diseases and areas:
- Dry eye
- Medical device site joint i…
6
Benzathine Benzylpenicillin

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Bacterial Infections and Mycoses, Diseases, Female Urogenital Diseases and Pregnancy Complications

Benzathine Benzylpenicillin, also known as Benzathine Penicillin G, is an antibiotic medication used in various clinical trials to treat different conditions. This article explores the use of this drug in clinical studies, focusing on its effectiveness, dosing, and potential benefits for patients with conditions like syphilis, streptococcal infections, and rheumatic heart disease.

Related diseases and areas:
1
Benzocaine

Hemic and Lymphatic Diseases, Neoplasms

Benzocaine is a local anesthetic commonly used in medical and dental procedures for its pain-relieving properties. This article examines various clinical trials investigating the efficacy and safety of benzocaine in different applications, from dental procedures to ear pain relief. These studies aim to better understand how benzocaine can be used effectively to manage pain and discomfort in various medical settings.

Related diseases and areas:
- Non-Hodgkin’s lymphoma
1
Benztropine Mesylate

Pathological Conditions, Signs and Symptoms

This article provides an in-depth look at clinical trials involving Benztropine Mesylate, a medication commonly used to treat Parkinson’s disease and certain side effects of antipsychotic drugs. We’ll explore its various applications, potential benefits, and side effects as investigated in several clinical studies. This overview aims to give patients and caregivers a better understanding of ongoing research into this important medication.

Related diseases and areas:
- Somatic symptom disorder
4
BENZYDAMINE HYDROCHLORIDE

Diseases, Otorhinolaryngologic Diseases, Respiratory Tract Diseases

Benzydamine hydrochloride is a non-steroidal anti-inflammatory drug (NSAID) with local analgesic and anti-inflammatory properties. It has been studied in various clinical trials for treating conditions such as postoperative sore throat, radiation-induced oral mucositis, and acute throat pain. This article examines the current research on benzydamine hydrochloride’s effectiveness and applications across different medical contexts, particularly focusing on its topical use in oral and throat conditions. Clinical trials have investigated various formulations including sprays, gargles, lozenges, and gels, providing insight into this medication’s role in managing pain and inflammation.
2
Benzyl Alcohol

Bacterial Infections and Mycoses, Diseases, Musculoskeletal Diseases, Nervous System Diseases

Benzyl alcohol is a compound being studied in clinical trials for various medical applications. Two notable studies focus on its use in treating head lice and investigating bronchial hyperreactivity. These trials aim to evaluate the effectiveness and safety of benzyl alcohol-based treatments, providing valuable insights into potential new therapies for patients.

Related diseases and areas:
- Primary progressive multipl…
- Medical device site joint i…
1
Benzylpenicillin

Bacterial Infections and Mycoses, Diseases, Musculoskeletal Diseases

Benzylpenicillin, also known as penicillin G, is an important antibiotic used in clinical trials to treat various bacterial infections. This article examines recent clinical studies investigating the use of benzylpenicillin for conditions like staphylococcal infections, syphilis, and streptococcal pharyngitis. We’ll explore different administration methods, dosing regimens, and how benzylpenicillin compares to other antibiotics in terms of effectiveness and patient outcomes.

Related diseases and areas:
- Osteomyelitis
4
BENZYLPENICILLIN POTASSIUM

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Bacterial Infections and Mycoses, Diseases, Female Urogenital Diseases and Pregnancy Complications

Benzylpenicillin potassium, also known as penicillin G potassium, is an important antibiotic used to treat various bacterial infections. This article explores how this medication is being studied in clinical trials for conditions ranging from neurosyphilis in HIV-positive individuals to severe pneumonia, complicated urinary tract infections, and Staphylococcus aureus bloodstream infections. These trials aim to determine optimal dosing regimens, effectiveness compared to other antibiotics, and innovative delivery methods to improve patient outcomes and reduce hospital stays.

Related diseases and areas:
- Preterm premature rupture o…
- Sepsis
4
BENZYLPENICILLIN PROCAINE

Analytical, Diagnostic and Therapeutic Techniques and Equipment, Anesthesia and Analgesia, Bacterial Infections and Mycoses, Diseases, Female Urogenital Diseases and Pregnancy Complications

Benzylpenicillin procaine, also known as procaine penicillin, is an antibiotic medication that combines benzylpenicillin with procaine to create a depot formulation. This combination allows for prolonged release of the antibiotic, extending its duration of action. Clinical trials involving benzylpenicillin procaine are exploring its efficacy in treating various infections, from sepsis in young infants to Staphylococcus aureus bacteremia and syphilis. This article examines the current research on benzylpenicillin procaine in clinical trials, including its applications, dosing regimens, and comparative effectiveness against other antibiotics.

Related diseases and areas:
- Sepsis
- Preterm premature rupture o…
7
Benzylpenicillin Sodium

Bacterial Infections and Mycoses, Diseases, Female Urogenital Diseases and Pregnancy Complications

Benzylpenicillin sodium, also known as penicillin G, is an antibiotic used to treat various bacterial infections. This article examines several clinical trials investigating the use of benzylpenicillin sodium for conditions like Staphylococcus aureus infections, neurosyphilis, and urinary tract infections. The trials explore different dosing regimens, administration methods, and comparisons to other antibiotics to determine the most effective treatment approaches.

Related diseases and areas:
5
Bepirovirsen

Diseases, Virus Diseases

Bepirovirsen is an investigational drug currently being studied in clinical trials for the treatment of chronic hepatitis B virus (HBV) infection. These trials aim to evaluate the safety, efficacy, and potential of bepirovirsen to achieve functional cure in patients with chronic HBV, either alone or in combination with other therapies. The studies involve various patient populations, including those on existing nucleos(t)ide analogue (NA) therapy and those co-infected with HIV.

Related diseases and areas:
- Chronic hepatitis B
2
Bepranemab

Diseases, Nervous System Diseases

Bepranemab, also known as UCB0107, is an investigational drug being studied for the treatment of Progressive Supranuclear Palsy (PSP). This article explores the ongoing clinical trials that are evaluating the safety, tolerability, and potential effectiveness of Bepranemab in patients with PSP. These trials aim to provide valuable insights into this promising treatment option for a challenging neurological condition.

Related diseases and areas:
- Progressive supranuclear palsy
- Dementia Alzheimer’s type
2
Berotralstat

Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diseases, Hemic and Lymphatic Diseases

Berotralstat, also known as BCX7353 or Orladeyo®, is a drug being studied in clinical trials for the treatment of hereditary angioedema (HAE). These trials aim to evaluate its safety, effectiveness, and proper dosing in various patient populations, including children. The studies focus on using berotralstat as a preventive treatment to reduce the frequency and severity of HAE attacks.

Related diseases and areas:
- Hereditary angioedema

Explore popular drugs in clinical trials

Starting by letter

Most popular drugs

New drugs in trials

#1 AZD0120

#2 STREPTOCOCCUS VIRIDANS

#3 STREPTOCOCCUS PYOGENES

#4 AZD1163

#5 AZD5335

#6 IMB 101

All drugs

We use cookies